Should you use a stool softener on Wegovy?

What the STEP 1 trial data tell us about constipation on semaglutide

The STEP 1 trial, published in the New England Journal of Medicine, remains the core evidence base for Wegovy's side-effect profile. Around 30% of participants on semaglutide 2.4mg reported constipation over 68 weeks, compared with roughly 11% on placebo. That gap is substantial. The pattern is not random. Semaglutide activates GLP-1 receptors in the gut wall and the enteric nervous system, slowing gastric emptying and overall intestinal transit. Less movement means more water is absorbed from the stool as it sits in the colon longer, producing harder, drier stools.

Constipation tended to be most noticeable early in treatment or after a dose increase, which fits with the same gut-slowing mechanism becoming more pronounced as the dose rises. For most people it settled over a few weeks without specific treatment; for others it remained a consistent feature of life on the medicine. Knowing that distinction matters when you are weighing whether to reach for a stool softener or to wait it out.

You can read more about broader gastrointestinal changes people report on semaglutide on the semaglutide and loose stool page, which covers the other end of that spectrum — because both can occur, sometimes alternating, particularly during dose transitions.

Where stool softeners sit in the management options

The NHS medicines page for semaglutide recommends practical first steps for constipation: drink plenty of water, eat more high-fibre foods, and keep as physically active as you reasonably can. These are not platitudes, fibre adds bulk that speeds transit even when gut motility is slightly suppressed, and dehydration makes hard stools harder.

Stool softeners work by drawing moisture into the stool rather than stimulating the bowel to contract. They are gentle, generally well tolerated, and do not interact with semaglutide in any documented way. However, most UK pharmacists and prescribers would suggest an osmotic laxative such as macrogol first, because osmotic agents work on both hardness and transit, giving you two levers at once. Stool softeners address softness without speeding movement, which may not be enough if your main problem is transit time rather than stool consistency.

Stimulant laxatives (such as senna or bisacodyl) are effective but are generally reserved for constipation that has not responded to gentler measures, and prolonged use is not recommended without clinical guidance. Your prescriber or pharmacist at a GPhC-registered pharmacy is well placed to advise which category fits your current symptoms.

Timing, routine and when to ask for help

Most people find that keeping a consistent routine helps. Taking your Wegovy pen on the same day each week, staying hydrated from the moment you wake, and not skipping meals entirely (under-eating removes the main stimulus for bowel movement) all reduce the chance of constipation deepening. One practical detail: keeping a large glass of water beside the kettle as a morning reminder to drink before anything else can make a genuine difference over weeks.

There are situations where self-management is not the right call. If constipation is accompanied by severe abdominal pain, bloating that does not resolve, or you cannot keep fluids down, contact your prescriber or call NHS 111. The same applies if you notice any change in stool colour: dark stools on Wegovy warrant medical assessment, and anything that looks like blood requires prompt attention, our page on blood in stool on Wegovy explains what to look for and what to do. It is also worth reading about whether Wegovy can cause black stool, as this is a specific colour change that sometimes prompts questions and needs its own explanation.

Rarely, severe constipation can contribute to faecal impaction, which does need clinical management. It is uncommon on semaglutide alone, but the risk rises if fluid intake drops significantly, which can happen when nausea reduces appetite for both food and drink.

How nume (sorry (how nume) manages this within ongoing care

Every repeat prescription at nume is personally reviewed by a GPhC-registered prescriber before it is issued) not auto-renewed. If constipation or any other side effect is troubling you, that review is the moment to raise it. Our prescribers can adjust the pace of dose titration, discuss appropriate over-the-counter options, or advise whether a temporary pause makes clinical sense, based on your full picture rather than a general protocol.

If you are considering starting treatment and want to understand what ongoing aftercare looks like, the Wegovy overview page covers the full treatment pathway, and you can explore weight-loss treatment options more broadly. Cost context for private treatment is covered on the Wegovy cost in the UK page, where we are transparent about what a legitimate private prescription includes.

If you are ready to talk to a prescriber about whether Wegovy is appropriate for you, check your eligibility with our clinical team.